NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK
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Neuroblastoma is among the most common extracranial solid tumors in pediatrics and carries a poor prognosis. In this study investigators looked at neuronal differentiation factor NeuroD1 and its role in regulating cell growth. NeuroD1 is known for its role in promoting cell motility in neuroblastoma but alternative actions of NeuroD1 remained unknown. Using mouse models and human tissue, researchers demonstrated that the knockdown of NeuroD1 resulted in the slowing of growth of cancer tissue. They further elucidated that this growth suppression was due to the attenuation of NeuroD1-induced ALK expression. This exciting work lends hope that a possible drug target might soon be discovered.doi: [10.1111/cas.12628](10.1111/cas.12628)

Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells
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Human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent of adult T-cell leukemia (ATL), which is an aggressive form of T-cell malignancy. Tumor suppressor gene BCL11B is known to be reduced in this form of cancer and Tax, an oncoprotein, is crucial in the immortalization of cells. In this study, Fujii and colleagues sought to determine whether Tax expression played a role in the suppression of BCL11B by *in vitro* experimentation with human HTLV-1 cell lines. They found that, indeed, Tax expression resulted in the downregulation of BCL11B at the transcription level and this was associated with the immortalization of these cells. This fascinating work lays important foundations for future researchers as these pathways are further delineated.doi: [10.1111/cas.12618](10.1111/cas.12618)

Identification of a novel E-box binding Pyrrole--Imidazole polyamide inhibiting MYC-driven cell-proliferation
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The MYC transcription factor plays a crucial role in the regulation of cell cycle progression, apoptosis, angiogenesis and cellular transformation. Due to its oncogenic activities and overexpression in a majority of human cancers, it is an interesting target for novel drug therapies. In this outstanding study, Nagase *et al*. developed a potential therapeutic drug that binds to the MYC E-box and inhibits the transcription of MYC products. The therapeutic drug, named MYC-5, was then injected into xenografted mice with MYC-dependent tumors and a significant decrease in tumor growth was noted without any evidence of serious toxicity. This study not only demonstrates how knowledge of biological pathways is important in the formation of drugs to combat cancers, but also perhaps reveals an important drug that could one day be used to save the lives of cancer patients.doi: [10.1111/cas.12610](10.1111/cas.12610)
